Method for treating hepatitis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 19, 2005
Grant Date -
Mar 28, 2002
app pub date -
Aug 10, 2001
filing date -
Aug 11, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Hepatitis can be treated by administering to a patient in need thereof an effective amount of a compound that neutralizes the effects of secreted TNFalpha. Two types of these compounds are extracellular ligand binding proteins of the human p75 TNF receptor, such as etanercept (Enbrel), and humanized monoclonal antibodies that neutralize the activity of TNFalpha, such as inflixamab (Remicade).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully